tm logo
Live/Registered
REGISTERED

on 14 May 2024

Last Applicant/ Owned by

180 3rd Avenue, Fifth Floor

Waltham

MA

02451

Serial Number

90980911 filed on 21st Aug 2020

Registration Number

7388468 registered on 14th May 2024

in the Principal Register

Correspondent Address

Peter Kunin DOWNS RACHLIN MARTIN PLLC

199 MAIN STREET, PO BOX 190

BURLINGTON, VT 05402-0190

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

Logo Mark Trademark Information

Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of neurological diseases The mark consists of a stylized downward facing arrow with an upside down triangle above the arrow

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of neurological diseases


First Use Date in General

05th Oct 2023

First Use Date in Commerce

05th Oct 2023

Mark Details


Serial Number

No 90980911

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 16694006UST1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.15.04 -

Arrowheads

26.05.21 -

Triangles that are completely or partially shaded

Description of Design Search

The mark consists of a stylized downward facing arrow with an upside down triangle above the arrow

Legal History


Show more

Status DateAction Taken
14th May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
14th May 2024REGISTERED-PRINCIPAL REGISTER
10th Apr 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09th Apr 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09th Mar 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
08th Mar 2024STATEMENT OF USE PROCESSING COMPLETE
08th Mar 2024DIVISIONAL PROCESSING COMPLETE
26th Feb 2024TEAS REQUEST TO DIVIDE RECEIVED
26th Feb 2024TEAS STATEMENT OF USE RECEIVED
26th Feb 2024USE AMENDMENT FILED